3/11
08:03 am
artv
Artiva Biotherapeutics (ARTV) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics (ARTV) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $18.00 price target on the stock.
3/10
05:22 pm
artv
Artiva Biotherapeutics GAAP EPS of -$3.43 [Seeking Alpha]
High
Report
Artiva Biotherapeutics GAAP EPS of -$3.43 [Seeking Alpha]
3/10
04:23 pm
artv
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
High
Report
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights [Yahoo! Finance]
3/10
04:05 pm
artv
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
High
Report
Artiva Biotherapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights
3/4
03:32 pm
artv
Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update [Yahoo! Finance]
Low
Report
Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update [Yahoo! Finance]
3/3
08:06 am
artv
Latigo Biotherapeutics Appoints Neha Krishnamohan as Chief Financial Officer and Chief Business Officer [Yahoo! Finance]
Low
Report
Latigo Biotherapeutics Appoints Neha Krishnamohan as Chief Financial Officer and Chief Business Officer [Yahoo! Finance]
2/25
08:25 am
artv
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/25
08:00 am
artv
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
Low
Report
Artiva Biotherapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
3/10
04:47 pm
artv
Form 4 Artiva Biotherapeutics, For: Mar 10 Filed by: Huston Thad Allen
High
Report
Form 4 Artiva Biotherapeutics, For: Mar 10 Filed by: Huston Thad Allen
3/10
04:35 pm
artv
Form S-8 Artiva Biotherapeutics,
High
Report
Form S-8 Artiva Biotherapeutics,
3/10
04:10 pm
artv
Form 10-K Artiva Biotherapeutics, For: Dec 31
High
Report
Form 10-K Artiva Biotherapeutics, For: Dec 31
3/10
04:07 pm
artv
Form 8-K Artiva Biotherapeutics, For: Mar 10
High
Report
Form 8-K Artiva Biotherapeutics, For: Mar 10
2/24
05:16 pm
artv
Form 3 Artiva Biotherapeutics, For: Feb 18 Filed by: Huston Thad Allen
Low
Report
Form 3 Artiva Biotherapeutics, For: Feb 18 Filed by: Huston Thad Allen
2/24
05:15 pm
artv
Form 8-K Artiva Biotherapeutics, For: Feb 18
Low
Report
Form 8-K Artiva Biotherapeutics, For: Feb 18
2/19
09:50 pm
artv
Form 4 Artiva Biotherapeutics, For: Feb 18 Filed by: Sorg Elaine K.
Medium
Report
Form 4 Artiva Biotherapeutics, For: Feb 18 Filed by: Sorg Elaine K.
2/19
09:42 pm
artv
Form 3 Artiva Biotherapeutics, For: Feb 18 Filed by: Sorg Elaine K.
Medium
Report
Form 3 Artiva Biotherapeutics, For: Feb 18 Filed by: Sorg Elaine K.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register